Cargando…

Astrocyte reactivity to Fas activation is attenuated in TIMP-1 deficient mice, an in vitro study

BACKGROUND: Tissue inhibitor of metalloproteinases-1 (TIMP-1) is a multifunctional secreted protein with pleiotropic actions, including the inhibition of matrix metalloproteinases (MMPs), cell death/survival and growth promoting activities. After inflammatory challenge, the levels of TIMP-1 are high...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogier, Crystel, Creidy, Rita, Boucraut, José, Soloway, Paul D, Khrestchatisky, Michel, Rivera, Santiago
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1325973/
https://www.ncbi.nlm.nih.gov/pubmed/16316466
http://dx.doi.org/10.1186/1471-2202-6-68
_version_ 1782126489565659136
author Ogier, Crystel
Creidy, Rita
Boucraut, José
Soloway, Paul D
Khrestchatisky, Michel
Rivera, Santiago
author_facet Ogier, Crystel
Creidy, Rita
Boucraut, José
Soloway, Paul D
Khrestchatisky, Michel
Rivera, Santiago
author_sort Ogier, Crystel
collection PubMed
description BACKGROUND: Tissue inhibitor of metalloproteinases-1 (TIMP-1) is a multifunctional secreted protein with pleiotropic actions, including the inhibition of matrix metalloproteinases (MMPs), cell death/survival and growth promoting activities. After inflammatory challenge, the levels of TIMP-1 are highly and selectively upregulated in astrocytes among glial cells, but little is know about its role in these neural cells. We investigated the influence of TIMP-1 null mutation in the reactivity of cultured astrocytes to pro-inflammatory stimuli with TNF-α and anti-Fas antibody. RESULTS: When compared to WT, mutant astrocytes displayed an overall increased constitutive gelatinase expression and were less responsive to Fas-mediated upregulation of MMP-9, of monocyte chemoattractant protein-1 (MCP-1) and of intercellular cell adhesion molecule-1 (ICAM-1), all markers of astrocyte inflammatory response. In contrast, TNF-α treatment induced all these factors similarly regardless of the astrocyte genotype. The incorporation of (3)H-thymidin, a marker of cell proliferation, increased in wild-type (WT) astrocytes after treatment with anti-Fas antibody or recombinant TIMP-1 but not in mutant astrocytes. Finally, lymphocyte chemotaxis was differentially regulated by TNF-α in WT and TIMP-1 deficient astrocytes. CONCLUSION: We provide evidence that the alteration of the MMP/TIMP balance in astrocytes influences their reactivity to pro-inflammatory stimuli and that Fas activation modulates the expression of members of the MMP/TIMP axis. We hypothesise that the Fas/FasL transduction pathway and the MMP/TIMP system interact in astrocytes to modulate their inflammatory response to environmental stimuli.
format Text
id pubmed-1325973
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-13259732006-01-24 Astrocyte reactivity to Fas activation is attenuated in TIMP-1 deficient mice, an in vitro study Ogier, Crystel Creidy, Rita Boucraut, José Soloway, Paul D Khrestchatisky, Michel Rivera, Santiago BMC Neurosci Research Article BACKGROUND: Tissue inhibitor of metalloproteinases-1 (TIMP-1) is a multifunctional secreted protein with pleiotropic actions, including the inhibition of matrix metalloproteinases (MMPs), cell death/survival and growth promoting activities. After inflammatory challenge, the levels of TIMP-1 are highly and selectively upregulated in astrocytes among glial cells, but little is know about its role in these neural cells. We investigated the influence of TIMP-1 null mutation in the reactivity of cultured astrocytes to pro-inflammatory stimuli with TNF-α and anti-Fas antibody. RESULTS: When compared to WT, mutant astrocytes displayed an overall increased constitutive gelatinase expression and were less responsive to Fas-mediated upregulation of MMP-9, of monocyte chemoattractant protein-1 (MCP-1) and of intercellular cell adhesion molecule-1 (ICAM-1), all markers of astrocyte inflammatory response. In contrast, TNF-α treatment induced all these factors similarly regardless of the astrocyte genotype. The incorporation of (3)H-thymidin, a marker of cell proliferation, increased in wild-type (WT) astrocytes after treatment with anti-Fas antibody or recombinant TIMP-1 but not in mutant astrocytes. Finally, lymphocyte chemotaxis was differentially regulated by TNF-α in WT and TIMP-1 deficient astrocytes. CONCLUSION: We provide evidence that the alteration of the MMP/TIMP balance in astrocytes influences their reactivity to pro-inflammatory stimuli and that Fas activation modulates the expression of members of the MMP/TIMP axis. We hypothesise that the Fas/FasL transduction pathway and the MMP/TIMP system interact in astrocytes to modulate their inflammatory response to environmental stimuli. BioMed Central 2005-11-29 /pmc/articles/PMC1325973/ /pubmed/16316466 http://dx.doi.org/10.1186/1471-2202-6-68 Text en Copyright © 2005 Ogier et al; licensee BioMed Central Ltd.
spellingShingle Research Article
Ogier, Crystel
Creidy, Rita
Boucraut, José
Soloway, Paul D
Khrestchatisky, Michel
Rivera, Santiago
Astrocyte reactivity to Fas activation is attenuated in TIMP-1 deficient mice, an in vitro study
title Astrocyte reactivity to Fas activation is attenuated in TIMP-1 deficient mice, an in vitro study
title_full Astrocyte reactivity to Fas activation is attenuated in TIMP-1 deficient mice, an in vitro study
title_fullStr Astrocyte reactivity to Fas activation is attenuated in TIMP-1 deficient mice, an in vitro study
title_full_unstemmed Astrocyte reactivity to Fas activation is attenuated in TIMP-1 deficient mice, an in vitro study
title_short Astrocyte reactivity to Fas activation is attenuated in TIMP-1 deficient mice, an in vitro study
title_sort astrocyte reactivity to fas activation is attenuated in timp-1 deficient mice, an in vitro study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1325973/
https://www.ncbi.nlm.nih.gov/pubmed/16316466
http://dx.doi.org/10.1186/1471-2202-6-68
work_keys_str_mv AT ogiercrystel astrocytereactivitytofasactivationisattenuatedintimp1deficientmiceaninvitrostudy
AT creidyrita astrocytereactivitytofasactivationisattenuatedintimp1deficientmiceaninvitrostudy
AT boucrautjose astrocytereactivitytofasactivationisattenuatedintimp1deficientmiceaninvitrostudy
AT solowaypauld astrocytereactivitytofasactivationisattenuatedintimp1deficientmiceaninvitrostudy
AT khrestchatiskymichel astrocytereactivitytofasactivationisattenuatedintimp1deficientmiceaninvitrostudy
AT riverasantiago astrocytereactivitytofasactivationisattenuatedintimp1deficientmiceaninvitrostudy